Pharmaqo Labs SR9009 (Stenabolic): Uses, Effects, Side Effects, and Safety Guide

Pharmaqo Labs SR9009 (Stenabolic)

Pharmaqo Labs SR9009 (Stenabolic) is marketed as an oral research compound containing SR9009, commonly known as Stenabolic. Unlike products such as Ostarine or Ligandrol, SR9009 is not a Selective Androgen Receptor Modulator (SARM). Instead, it is a synthetic REV-ERBα/REV-ERBβ agonist that was originally developed for laboratory research into circadian rhythm, metabolism, and energy regulation.

SR9009 remains an investigational compound and has not been approved for medical use by the U.S. Food and Drug Administration (FDA) or any major regulatory authority.

General product information:

• Product Name: Pharmaqo Labs SR9009
• Active Ingredient: SR9009
• Common Name: Stenabolic
• Dosage Form: Oral capsules
• Compound Class: Investigational REV-ERB agonist
• Administration: Oral

Products obtained outside regulated pharmaceutical supply chains may vary in authenticity, purity, potency, and manufacturing quality.

---

What Is Pharmaqo Labs SR9009?

Pharmaqo Labs SR9009 is marketed as an oral research compound containing SR9009 (Stenabolic).

General product details:

• Compound: SR9009
• Common Name: Stenabolic
• Administration: Oral
• Category: Experimental metabolic modulator

SR9009 was designed as a laboratory tool for studying REV-ERB nuclear receptors, which help regulate the body’s biological clock (circadian rhythm), metabolism, and energy balance. It has not progressed to approved human therapeutic use.

---

What Is SR9009 (Stenabolic)?

SR9009 is a synthetic small-molecule REV-ERB agonist.

Unlike anabolic steroids or SARMs, SR9009 does not activate androgen receptors.

Research has investigated SR9009 for its potential effects on:

• Circadian rhythm regulation
• Energy metabolism
• Fat metabolism
• Exercise physiology
• Inflammation

Most published findings come from animal and laboratory studies, and there are no completed human clinical trials demonstrating safety or effectiveness.

---

How Does SR9009 Work?

SR9009 activates REV-ERBα and REV-ERBβ nuclear receptors.

Laboratory research suggests this may influence:

• Circadian clock genes
• Cellular energy metabolism
• Mitochondrial activity
• Glucose metabolism
• Lipid metabolism

These mechanisms have largely been demonstrated in laboratory and animal models rather than in humans.

---

SR9009 in Fitness and Bodybuilding Discussions

Within bodybuilding and fitness communities, SR9009 is commonly discussed for:

• Fat-loss support
• Endurance enhancement
• Body recomposition
• Cutting phases
• Training performance

These are not approved medical indications, and available evidence in humans is extremely limited.

---

Potential Effects Discussed by Users

Reported or discussed effects may include:

• Improved endurance
• Increased training capacity
• Fat-loss support
• Changes in body composition
• Increased energy levels

Because there are no published human clinical trials, these reported effects have not been confirmed in controlled clinical studies.

---

Hormonal Effects

Unlike anabolic steroids and SARMs:

• SR9009 does not directly stimulate androgen receptors
• It is not known to significantly suppress testosterone production
• It primarily acts through REV-ERB receptors involved in metabolism and circadian regulation

However, the absence of long-term human studies means its full hormonal effects remain uncertain.

---

Possible Side Effects

Because SR9009 has not undergone clinical development in humans, its complete safety profile is unknown.

Potential concerns include:

• Fatigue
• Sleep pattern changes
• Headache
• Unknown long-term metabolic effects
• Possible liver-related concerns
• Unknown cardiovascular effects

Researchers emphasize that chronic modulation of circadian biology may carry risks that have not yet been characterized in humans.

---

Research Limitations

One important limitation is that:

• Most positive findings come from mouse studies
• Published efficacy studies generally used intraperitoneal or intravenous administration
• There is little or no clinical evidence supporting the effectiveness of oral SR9009 in humans

These limitations should be considered when evaluating claims made for commercial products.

---

Sports and Anti-Doping Considerations

SR9009 is prohibited at all times under the World Anti-Doping Agency (WADA) Prohibited List as a metabolic modulator.

Athletes using SR9009 risk anti-doping violations.

---

Product Quality Considerations

Products marketed outside regulated pharmaceutical systems may vary in:

• Active ingredient concentration
• Purity
• Manufacturing consistency
• Label accuracy

Potential concerns include:

• Mislabeling
• Counterfeit products
• Contamination
• Undeclared active ingredients

Because SR9009 is an investigational compound, commercial products are not subject to the same regulatory standards as approved medicines.

---

Storage Recommendations

Store the product:

• In a cool, dry place
• Away from direct sunlight
• In the original packaging
• Out of reach of children

Do not use products that:

• Have damaged packaging
• Appear altered
• Have expired

---

Frequently Asked Questions

What is Pharmaqo Labs SR9009 (Stenabolic)?

It is marketed as an oral research compound containing SR9009 (Stenabolic), an investigational REV-ERB agonist.

Is SR9009 a SARM?

No. Despite often being sold alongside SARMs, SR9009 is not a SARM and does not act through androgen receptors.

Is SR9009 approved for bodybuilding?

No. SR9009 has not been approved for bodybuilding, athletic performance enhancement, or any medical indication.

Are there human clinical trials on SR9009?

No completed human clinical trials have established the safety or effectiveness of SR9009. Most available evidence comes from laboratory and animal studies.

Is SR9009 banned in sports?

Yes. SR9009 is prohibited by the World Anti-Doping Agency (WADA) as a metabolic modulator.

---

Final Thoughts

Pharmaqo Labs SR9009 (Stenabolic) is marketed as an oral investigational REV-ERB agonist designed for research into metabolism and circadian biology. Unlike SARMs, it does not activate androgen receptors. Although it is frequently discussed in bodybuilding communities for endurance and body recomposition, SR9009 is not approved for medical use or athletic performance enhancement, and there are no completed human clinical trials confirming its safety or effectiveness. Long-term health effects remain uncertain, and competitive athletes should be aware that it is prohibited under WADA regulations.

Disclaimer: This article is provided for educational and informational purposes only. It is not medical advice and should not replace consultation with a qualified healthcare professional.